Home
>
National Drug Code (NDC)
>
ANASTROZOLE
ANASTROZOLE - 51991-620-10 - (ANASTROZOLE)
Drug Information of ANASTROZOLE
| Product NDC: | 51991-620 |
| Proprietary Name: | ANASTROZOLE |
| Non Proprietary Name: | ANASTROZOLE |
| Active Ingredient(s): | 1 mg/1 & nbsp; ANASTROZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ANASTROZOLE
| Product NDC: | 51991-620 |
| Labeler Name: | Breckenridge Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079220 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100628 |
Package Information of ANASTROZOLE
| Package NDC: | 51991-620-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (51991-620-10) |
NDC Information of ANASTROZOLE
| NDC Code | 51991-620-10 |
| Proprietary Name | ANASTROZOLE |
| Package Description | 1000 TABLET in 1 BOTTLE (51991-620-10) |
| Product NDC | 51991-620 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ANASTROZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100628 |
| Marketing Category Name | ANDA |
| Labeler Name | Breckenridge Pharmaceutical, Inc. |
| Substance Name | ANASTROZOLE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
